focus -WSS

focus

author：Wikipedia 2025-10-01 06:01:13 - browse：129

Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research within the Food and Drug Administration, at a hearing — policy coverage from STAT — Peter Marks, director of the FDA's Center for Biologics Evaluation and Research Greg Nash/Pool via AP

WASHINGTON — A top Food and Drug Administration official wants Congress to dedicate full-time staff to emerging pathogens, after the FDA scrambled to find people for Covid-19 priorities like Operation Warp Speed.

“Vaccines were a pretty heavy duty lift during the pandemic,” said Peter Marks, director of the Center for Biologics Evaluation and Research, at a Thursday Politico event. “Rather than having to essentially reassign whole groups of people and disrupt things, the idea is to have a group of people who are constantly working on this.”

There is reason for optimism. Sens. John Hickenlooper (D-Colo.) and Ted Budd (R-N.C.) successfully added an amendment creating that team to a key pandemic preparedness bill that must be reauthorized by the end of September. It would establish this new program within Marks’ division of the FDA, staffed with experts on vaccines, antibodies, diagnostic tests, personal protective equipment, and other medical countermeasures. Among other activities, this team would enhance surveillance programs and prioritize vaccine research and development so that existing platforms can be retooled to fight other viruses.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Emergency workers more likely to restrain Black patients: study

Wikipedia

WSS

Intarcia’s device

Emergency workers more likely to restrain Black patients: study

Case for ALS therapy Nurown relies on ‘deficient’ data, FDA finds

AstraZeneca, Daiichi breast cancer treatment succeeds in trial

Inari Medical to buy amputation prevention company LimFlow

Thermo Fisher plant for manufacturing gene therapies to expand

focus

focus

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Thermo Fisher plant for manufacturing gene therapies to expand

After affirmative action ruling, medical educators look to 'holistic review'

STAT Readout: The latest on Wegovy, Mounjaro, and Covid shots

The high cost of giving birth even with insurance

The health care issue Democrats can’t solve: hospital reform

State Dept. review finds Biden bears some blame for Afghanistan failures

Why are Kaiser Permanente staff considering a strike?

New air purifier tech could be key to improving indoor air quality

Inari Medical to buy amputation prevention company LimFlow

hotspot

Inari Medical to buy amputation prevention company LimFlow

Senators: Long

How to convince healthy people to buy insurance

Life sciences investors close nearly $6 billion in new funds

Changes to biosimilar regulatory framework must prioritize patients

DeepMind touts AlphaFold's new skills as protein folding AI models face off

Wikipedia

knowledge

explore

leisure time